Skip to main content

Diabetes Mellitus: Pathophysiology

 PATHOPHYSIOLOGY OF DM

IMPAIRED INSULIN SECRETION

  • A pancreas with normal Beta cell function is able to adjust insulin production to maintain normal blood glucose levels.
  • Hyperinsulinemia or high blood levels of insulin is an early finding of T2 DM.
  • More insulin is secreted to maintain normal blood glucose levels until eventually the pancreas can no longer produce sufficient insulin.
  • Impaired Beta cell function results in reduced ability to produce a first-phase insulin response sufficient to signal the liver to stop producing glucose after a meal.
  • As DM progresses, large numbers of patients with T2DM eventually loses all beta cell function and require exogenous insulin to maintain the blood glucose levels. 


INSULIN RESISTANCE

  • Insulin resistance is the primary factor that differentiates T2DM from other forms of diabetes.
  • Insulin resistance maybe present for several years prior to the diagnosis of DM.
  • Insulin resistance occurs more significantly in skeletal muscles and liver.
  • Insulin resistance in the liver poses a double threat because the liver becomes nonresponsive to insulin for glucose uptake and hepatic production of glucose after a meal does not cease which leads to elevated fasting and post-meal glucose levels.


IMAPIRED GLUCAGON SECRETION

  • Glucagon is the counter regulatory hormones produced by the beta cells that raises blood glucose levels.
  • The release of insulin and the inhibition of glucagon is glucose stimulated.
  • Most patients with a 10–20-year history of T1DM have lost their ability to release glucagon, which increases their risk of hypoglycemic unawareness.



GLUCAGON LIKE PEPTIDE AND GIP IMAPIRED 

People with T2DM have impaired phase 2 insulin release, and some have impaired glucagon-like peptide (GLP-Q) and glucose-dependent insulinotropic polypeptide (GIP) release, which further reduces the release of insulin.

Comments

Popular posts from this blog

Drug-Induced Ototoxicity!

 DRUG-INDUCED OTOTOXICITY What is drug Induced Ototoxicity? Drug-Induced ototoxicity can affect hearing (auditory or cochlear function0, balance (vestibular function) depending on the drug. Drugs of almost every class have been reported to produce tinnitus (sounds in ear), as have placebos. The following agents are associated with measurable changes in hearing or vestibular defect when administered systemically. 1. AMINOGLYCOSIDES: Aminoglycosides antibiotics can cause cochlear or vestibular toxicities. Cochlear toxicity: occurs as progressive hear loss, starting with highest tones and advancing to lower tones. Thus, considerable damage can occur before the patient recognizes it. S ymptoms of Vestibular damage : include;  Dizziness Vertigo Ataxia Both forms of ototoxicity are bilateral and potentially reversible, but permanent damage is common and can progress even after discontinuation of aminoglycosides. Clinically detectable ototoxicity in as many as 5% patients. Most amin...

Diabetes Mellitus: Non-Pharmacological Therapy--MNT!

 NON PHARMACOLOGICAL THERAPY  MNT Glycemic Index Dietary supplements Weight measurements Physical Activity Psychological assessment Immunizations 1. MEDICAL NUTRITION THERAPY (MNT)  " Medical Nutrition Therapy (MNT) is a term used by the ADA to describe the optimal condition of caloric intake with other aspects of diabetes therapy (Insulin, Exercise, Weight loss)". The ADA has issued recommendations for three types of MNT: Primary prevention measures of MNT are directed at preventing or delaying the onset of type 2 Diabetes in high-risk individuals (obese or with pre-diabetes) by promoting weight reduction. Secondary prevention measures of MNT are directed at preventing or delaying-related complications in diabetic individuals by improving glycemic control. Tertiary prevention measures of MNT are directed at managing diabetes-related complications (cardiovascular disease, neuropathy) in diabetic individuals. Despite the popular notion, there is not any " Diabetic diet...

Medical Emergency- Cardiac Arrest and Basic Life Support (BLS)!

  MEDICAL EMERGENCY- CARDIAC ARREST AND BASIC LIFE SUPPORT Definition: " Cardiac Arrest is a medical emergency requiring a systematic approach". Early recognition must be followed by prompt, effective application of Basic Life Support (BLS) techniques to sustain the patient until Advanced Life Support (ALS) capabilities are available. Management: The management of Cardiac Arrest is a 4-step approach: Recognition and Assessment BLS Advanced Cardiovascular Life Support (ACLS) Post-resuscitation Care 1. RECOGNITION AND ASSESMENT Verify that the respiration and circulation have ceased: Loss of consciousness Loss of functional ventilation (respiratory arrest or inadequate respiratory effort) Loss of functional perfusion (No pulse). 2. BASIC LIFE SUUPORT (BLS) The goal in cardiac arrest is the restoration of spontaneous circulation (ROSC). The first step towards achieving this ROSC goal is prompt initiation of BLS, where the goal is to rapidly and effectively perfuse the tissues wi...